Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 114 publications
Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b study.
Journal: Lancet (London, England)
Published: October 30, 2025
Short- and long-term effects of early versus delayed treatment with ocrelizumab on cerebellar volume loss in patients with RMS and PPMS.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: April 16, 2025
Depression Polygenicity and Disease Activity and Disability Worsening in Multiple Sclerosis.
Journal: Annals of neurology
Published: February 28, 2025
Ethnoracial disparities in gray matter atrophy are mediated by structural disconnectivity in multiple sclerosis.
Journal: Annals of clinical and translational neurology
Published: September 24, 2024
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials.
Journal: The Lancet. Neurology
Published: May 16, 2024
Efficacy and safety results after >3.5 years of treatment with the Bruton's tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: March 04, 2024
Detection of diffusely abnormal white matter in multiple sclerosis on multiparametric brain MRI using semi-supervised deep learning.
Journal: Scientific reports
Published: January 22, 2024
Polygenic liability for anxiety in association with comorbid anxiety in multiple sclerosis.
Journal: Annals of clinical and translational neurology
Published: January 12, 2024
Relapse recovery in relapsing-remitting multiple sclerosis: An analysis of the CombiRx dataset.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: October 13, 2023
Identifying the white matter pathways involved in multiple sclerosis-related tremor using diffusion tensor imaging.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: August 18, 2023
The impact of relapse definition and measures of durability on MS clinical trial outcomes.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: April 29, 2023
Trigeminal neuralgia in multiple sclerosis: Association with demyelination and progression.
Journal: Multiple sclerosis and related disorders
Published: February 08, 2023
Last Updated: 09/26/2026